Home > Leadership Team

Meet Our Team

From product design and clinical expertise to commercial acumen, our visionary leadership team has the extensive experience needed to turn novel concepts into groundbreaking medical devices.

Together, we are transforming the way care is delivered — helping patients overcome the challenges of calcified arterial disease to live more fulfilling lives.

Executive Leadership

Mark Toland

Executive Chairman

Read Bio

Robert Chisena, PhD

Co-Founder & Chief Technology Officer

Read Bio

Sean Gilligan

Chief Operations Officer

Read Bio

Angie Volk, Vice President of Business Development

Angie Volk

Vice President of Business Development

Read Bio

Liz Galle, Vice President of Clinical Affairs

Liz Galle

Vice President of Clinical Affairs

Read Bio

Susie McAfee, VP of People and Adminstraton

Susie McAfee

VP of People and Administration

Read Bio

Rob Lavado, Vice President of Regulatory and Quality

Rob Lavado

Vice President of Regulatory and Quality

Read Bio

Bob Haller

Corporate Controller

Read Bio

Medical Advisors

Board of Directors

Mark Toland

Executive Chairman

Read Bio

Louis Cannon, MD

Founder & Senior Managing Director, BioStar Capital

Read Bio

William H. (Hank) Kucheman

Director, BioStar Capital

Read Bio

Jason Richardson

Independent Board Director, MPA

Read Bio

Investors & Support

Cue Growth Partners Logo

Pioneering Innovative Solutions for Calcified Arterial Disease

Founded in 2017 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at the University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer, AVS is redefining interventional therapy for severely calcified lesions — and we’re revolutionizing intravascular lithotripsy.

More about AVS

Let’s Talk.

Looking to learn more about the innovative Pulse IVL™ or about AVS?

Reach Out Today